Inmunogenicidad de la vacuna Heberbiovac-HB en impedidos físicos y mentales

Pedroso Flaquet, Placido; Díaz González, Manuel; Rodríguez Lay, Licel; Bravo González, José R.
Rev. cuba. med. trop ; 49(1): 59-63, 1997. graf
Artículo en Español | LILACS | ID: lil-208303

Documentos relacionados

  1. A Dengue Vaccine.
  2. Predictive Factors for Successful Vaccination Against Hepatitis B Surface Antigen in Patients Who Have Undergone Orthotopic Liver Transplantation.
  3. Expression and detection of anti-HBs antibodies after hepatitis B virus infection or vaccination in the context of protective immunity.
  4. Serum levels of anti-hepatitis B surface antibodies among vaccinated children aged 1 to 12 years in a rural community in Fars Province, southern Iran.
  5. Creation of superagonist epitope sequences in the hepatitis B envelope protein using mutagenesis and DNA vaccination.
  6. [Persistence of immune memory and its related factors at 12 years after hepatitis B vaccination among adults].
  7. Improvement of hepatitis B vaccine to induce IFN-γ cytokine response: A new formulation.
  8. Maximizing anti-HBs seroresponsiveness in kidney transplant waitlist patients: A tertiary-center perspective
.
  9. Hepatitis-B Vaccine Response in Inflammatory Bowel Disease Patients: A Systematic Review and Meta-analysis.
  10. Baseline exposure, antibody subclass, and hepatitis B response differentially affect malaria protective immunity following RTS,S/AS01E vaccination in African children.